Genetic Testing for Prostate Cancer:
What tools do men need to make an informed decision about germline genetic testing for prostate cancer: A qualitative and survey study | medRxiv What Every Patient Should Know in 2026 A new wave of guidelines, approved therapies, and patient-centered tools is making germline genetic testing a standard part of prostate cancer care — but most men still haven't been tested. Here's what you need to know. Bottom Line Up Front (BLUF) Germline genetic testing — a blood or saliva test that looks for inherited gene changes — has become a cornerstone of prostate cancer care in 2025–2026. Both ASCO and NCCN now recommend it broadly for men with metastatic, high-risk, or locally advanced disease, and for men with relevant family histories. Knowing your genetic status can guide which treatments will work best for you (including PARP inhibitors like olaparib and rucaparib), alert your sons, brothers, and other relatives to start screening earlier, and reve...